RxDoctor Payments Data

Mandy McMillan

Physician Assistant · Nashville, GANPI 1356777205

Payments from drug & device makers

$1,949in general payments, 2019–2025

Across 119 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$689
  • GSK$288
  • Dexcom, Inc.$159
  • AstraZeneca$125
  • Lilly USA, LLC$100
  • Bayer$69
  • plus $518 from 16 others

What the payments were for

  • Food & beverage$1,949100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,949 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin94$89,616
OzempicSemaglutide83$81,914
MounjaroTirzepatide59$62,461
TradjentaLinagliptin72$60,374
LinzessLinaclotide51$55,765
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$53,108
VraylarCariprazine Hcl36$52,489
RybelsusSemaglutide25$42,098
JanuviaSitagliptin Phosphate31$30,968
EliquisApixaban50$29,444
MyrbetriqMirabegron45$29,191
XareltoRivaroxaban28$25,087
BelsomraSuvorexant30$16,072
FarxigaDapagliflozin Propanediol14$14,928
Breo ElliptaFluticasone/Vilanterol21$12,235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$48$149,990166 claims
Novo NordiskOzempic, Rybelsus, Levemir$63$127,518120 claims
AbbVieLinzess, Vraylar, Qulipta$689$120,30599 claims
GSKTrelegy Ellipta, Breo Ellipta$288$65,34377 claims
Lilly USA, LLCMounjaro$100$62,46159 claims
MerckJanuvia, Belsomra$37$47,04061 claims
PfizerEliquis$12$29,44450 claims
Astellas Pharma US IncMyrbetriq$20$29,19145 claims
Johnson & JohnsonXarelto$15$25,08728 claims
AstraZenecaFarxiga, Breztri Aerosphere$125$24,84929 claims
NovartisEntresto$23$8,50911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Nashville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →